Exhibition Introduction

Industry background

The field of life science is a typical discipline that embodies the highly interdisciplinary and integrated nature of disciplines, and it is also currently the most influential discipline in China internationally. It is most likely to achieve the transition from following to running and leading. Life science innovation research and pharmaceutical industrialization have become important soft power of China. With the innovation breakthroughs in life science and biotechnology, the global life science is booming, and the fields of artificial intelligence, big data and life science are gradually integrated. The implementation of the "Law of Biological Safety of the People's Republic of China" will usher in unprecedented development opportunities for the development of biotechnology industry, and also bring huge business opportunities for the development of life science, biotechnology and upstream and downstream industries.

Conference Introduction

The 2026 China Life Science Conference and China Life Science Expo, guided by the National Health Commission, supported by the Guangdong Provincial Health Commission, hosted by the Guangzhou Municipal People's Government and the Guangzhou Municipal Health Commission, and jointly organized by the Guangdong Provincial Medical Security Bureau, Guangdong Provincial Drug Administration, Guangdong Provincial Hospital Association, and Guangzhou Hospital Association, will be held from August 21-23, 2026 at the China Import and Export Fair Exhibition Hall (collectively referred to as CLSE).

CLSE to With the theme of "Global Community of Life and Health, One World, Shared Health", nearly 100 themed forums were held during the exhibition, inviting leaders from government regulatory departments, gathering nearly 30 Chinese and foreign academicians, and bringing together top experts from academia, industry, and investment, including renowned scientists, clinical medicine experts, leading entrepreneurs, senior investors, and technology research and development backbones. Through in-depth exchanges and discussions, global development trends, cutting-edge progress, biotechnology innovation, and future industrial layout in the field of life sciences were discussed, focusing on mainstream themes, exploring frontiers and foresight, and building an international high-end practical platform for experts and industry leaders to share academic achievements and experience exchange. Through rich exhibition content and exciting series of academic activities, a globally influential platform was constructed. The transformation of scientific and technological achievements and the exchange of cutting-edge technologies With its large scale, high specification, strong academic leadership, closer integration with industry and far-reaching influence, the conference has formed a wide range of international influence, and has become a world brand conference under the "the Belt and Road" initiative.

The "China Life Science Conference and China Life Science Expo" is the only event in China, hosted by the National Health Commission, aimed at the field of life sciences. It leads the development and progress of the industry with new quality productivity, continuously injects new vitality into the life science industry, and promotes the industry to new heights and depths. With a super large scale of 80000 square meters, 1000 companies participated in the exhibition, and more than 100000 professional visitors attended, it is also an excellent platform for exhibiting companies to promote products, exchange experiences, meet people, deepen friendship, promote cooperation, showcase achievements, and demonstrate strength!

Here it is! We sincerely invite you to bring an elite team, a grand and beautiful image, and high-tech products to showcase, because we have prepared everything for you and business opportunities are waiting for you!

Sub forum

Based on modern cutting-edge biotechnology, focusing on the health challenges faced by the public, and jointly committed to relying on life sciences and biotechnology to overcome major diseases that endanger human health and improve human welfare. The 2026 China Life Science Conference will have group forums covering molecular diagnostics, new drug research and development, antibody drugs, cell and gene therapy, mRNA, epigenetics, single cell, multi-omics, biological big data, vaccines, antibodies, exosomes, tumor early screening, tumor detection, organ transplantation, etc. There are plans for more than 100 group forums, with a scale of 100-300 participants for each forum.

Theme sub-forum (proposed)

·General Cell Drug Development Summit

·Clinical research and transformation of stem cells

·Innovative drug development and technological innovation

·Antibody drug development and target screening

·Mass Spectrometry Technology and Clinical Application

·Autoimmune and tumor immunity

·Reproduction and Genetics Summit Forum

·Metabolomics & Proteomics Forum

·Precision diagnosis and treatment of tumors

·Early screening and diagnosis of cancer

·Inspection Medicine Development Forum

·Biopharmaceutical Technology Development Summit

·Application of cutting-edge technologies in cell and gene therapy

·Molecular diagnostic techniques for infectious diseases

·Vaccine and antibody

·Cell therapy research and development and industrialization

·Single cell multi-omics research and clinical application

·Clinical Application Forum of Flow Cytometry Technology

·Laboratory Construction and Development Forum

·Experimental Animal Forum

·Gene therapy and oncolytic virus

·The frontier progress layout of gene therapy and nucleic acid drugs

·Organoid and 3D Cell Culture Session

·ITBT&AI Pharmaceutical Forum

·Biomedical big data and artificial intelligence

·Intestinal Ecology and Health Forum

·Young Scientists Forum

·Breakthroughs in new drug research and development

·Nucleic acid drugs

·ADC drugs

·Analytical R&D & Quality Control Forum (Antibody Drug Session)

·Analyze R&D & quality control (cells & genes & vaccines)

·Special Session on Gene Drugs

·Production and Quality Management Forum

·Biopharmaceutical investment and financing